PDCD1 and hepatocellular carcinoma: Moreover, inhibition of SQLE with the clinically available drug terbinafine enhanced the efficacy of anti-PD1 therapy, and SQLE expression was associated with better responses to anti-PD1 treatment in patients with HCC.